Papers
2
Total Citations
140
H-Index
2
About
Francesco Fidanza is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for renal and prostate cancers. His most impactful contribution is the landmark multicenter study from the RECORd Project, which systematically compared open, laparoscopic, and robot-assisted partial nephrectomy for clinical T1b renal tumors. This work, cited over 130 times, provided critical evidence that robot-assisted approaches can achieve oncologic outcomes comparable to traditional surgery while offering the benefits of reduced morbidity. Fidanza has also investigated perioperative optimization in urologic oncology, notably through a retrospective analysis evaluating the hemostatic efficacy of FloSeal in robot-assisted laparoscopic radical prostatectomy. This study addressed a key clinical challenge—bleeding during RALP—and contributed practical insights into improving surgical safety. By combining rigorous comparative effectiveness research with a focus on technical refinement, Fidanza has helped shape modern standards for nephron-sparing surgery and robotic prostatectomy. His work continues to influence how urologists balance oncologic control with functional preservation, making him a respected voice in the field of robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2